Lexeo Therapeutics, Inc. Common StockLXEONASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank100
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

Latest
45.00%
↑ 1712% vs avg
Percentile
P100
Near historical high
Streak
2 qtr
Consecutive growthAccelerating
Average
-2.79%
Historical baseline
PeriodValue
Q3 202545.00%
Q2 202539.39%
Q1 2025-26.92%
Q4 202412.36%
Q3 2024-39.06%
Q2 202416.88%
Q1 2024-48.08%
Q4 202335.00%
Q3 2023-50.94%
Q2 202328.38%
Q1 2023-27.59%
Q4 202214.71%
Q3 2022-13.33%
Q2 2022-27.66%
Q1 20220.00%